FCM
PGNX

Farallon Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Farallon Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,250,000
Closed -$31.4M – 135
2020
Q1 		$31.4M Hold
8,250,000
– – 0.29% 54
2019
Q4 		$42M Buy
8,250,000
+900,000
+12% +$4.76M 0.32% 61
2019
Q3 		$37.2M Buy
7,350,000
+1,806,614
+33% +$9.01M 0.3% 53
2019
Q2 		$34.2M Buy
5,543,386
+1,342,566
+32% +$6.47M 0.24% 63
2019
Q1 		$19.5M Hold
4,200,820
– – 0.16% 73
2018
Q4 		$17.6M Buy
4,200,820
+588,000
+16% +$2.99M 0.15% 71
2018
Q3 		$22.7M Buy
3,612,820
+961,720
+36% +$7.39M 0.16% 63
2018
Q2 		$21.3M Buy
+2,651,100
New +$20.2M 0.16% 63

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.6B AUM 20.7% 1-Year Est. Return